Stress urinary incontinence is the involuntary leakage of urine that occurs with increased intra-abdominal pressure, most commonly when laughing, coughing, sneezing, running or jumping. The issue affects nearly 2 out 5 women worldwide.
Stress urinary incontinence is the involuntary leakage of urine that occurs with increased intra-abdominal pressure, most commonly when laughing, coughing, sneezing, running or jumping. The issue affects nearly 2 out 5 women worldwide.

The average age of presentation for Stress Urinary Incontinence in Australia is 50-60 years old and commonly occurs after vaginal childbirth. Understandably, leaking urine throughout the day has a hugely detrimental impact on the quality of life for women. The good news is that Stress incontinence management overall has great long term outcomes in regards to no more leakage, high patient satisfaction, quick recovery and low complication rates.

As a certified Urogynaecologist with subspecialty training, Dr Usama Shahid offers expert assessment and management of stress urinary incontinence including complex or recurrent cases. With a focus on holistic care he leads the stress urinary incontinence specialist Wollongong service offering the full range of evidence based treatments, including both mesh and non mesh options. Dr Shahid's focus lies in providing a personalised plan with the goal of achieving durable results and restoring confidence in everyday activities to the women of the Illawarra.

What are the types of
urinary incontinence?

There are 2 main branches of female urinary incontinence, namely stress urinary incontinence and overactive bladder syndrome.

Overactive bladder is characterised by urge urinary incontinence (where you cant defer the need to go urinate and have to leave what you are doing and rush off to the bathroom). This is related to dysfunction of the complex circuit of nerve fibres running from the brain, to the spinal cord and then to the bladder and discussed separately here. Bladder control is significantly reduced and frequent urination and urge urinary incontinence results. Treatment options include optimising bladder function through bladder training, kegel exercises, bladder botox and sacral nerve stimulation

Stress urinary incontinence on the other hand, is characterised by leakage of urine when you laugh, cough, sneeze, run or jump. This is usually related to the urethra being hypermobile (lacking anatomical supports).

There are other specific types of incontinence including mixed urinary incontinence and overflow incontinence (from chronic urinary retention) which are managed as part of the above conditions.

What causes Stress
Urinary Incontinence?

In order to maintain continence with increased abdominal pressure, several parts of the pelvic floor need to be functioning together in a coordinated fashion. These include the urethral sphincter, pelvic floor muscles, the endopelvic fascia and pubo-urethral ligament. Damage to these tissues (most commonly following vaginal childbirth) means that the urethra becomes hypermobile, as its natural pelvic supports have been weakened or avulsed. Consequentially, a hypermobile urethra means that the bladder neck moves freely with increased abdominal pressure (laughing, coughing, sneezing, running and jumping) and urine leakage results. Less commonly, stress urinary incontinence can result from intrinsic sphincter deficiency, which is an internal defect in the urinary sphincter closing mechanism. Urodynamics and pelvic floor ultrasound are used to help differentiate between these types of stress incontinence as their management can vary.


The risk factors for Stress Urinary Incontinence include:

  • Vaginal birth: particularly forceps deliveries, large babies (>4.5kg) or prolonged labour. The more vaginal deliveries an individual has had, the more likely they are to develop stress incontinence.

  • Obesity: Obesity places continual abdominal pressure on the pelvic floor which over time can displace the pelvic supports of the urethra. Lifestyle changes towards losing weight are a pivotal part of any stress urinary incontinence treatment plan.

  • Chronic cough which places recurrent pressure on the pelvic floor muscles and vaginal tissues.

  • Persistent heavy lifting, similarly also places recurrent pressures on the pelvic floor and urethral supports.

  • Ethnicity: Stress incontinence is more common amongst Caucasian women.

  • General medical issues like Diabetes and cigarette smoking.

  • Connective tissue disorders like Ehlers Danlons Syndrome result in pelvic tissues which are more mobile.

  • Neurological conditions: spinal cord trauma, cerebral palsy, multiple sclerosis, dementia can all affect pelvic floor muscle coordination.

  • Previous urethral surgery, trauma or radiation.
Watch and wait

Observing symptoms only with ongoing follow up and re-discussion about all treatment options.

Conservative management
(non surgical treatments)
Pelvic floor muscle training

Pelvic floor muscle training is a coordinated program of supervised exercises done with a healthcare professional. It forms the backbone of conservative treatments for SUI. The aim of pelvic floor exercises is to strengthen and support the muscles of the pelvic floor in women, thereby decreasing urethral hypermobility and urinary incontinence symptoms. Dr Shahid works closely with several local physiotherapists specialising in pelvic floor exercises to keep your pelvic floor muscles strong and effectively support your pelvic organs. Below is a basic regime you can implement while awaiting review:


  • Slow, sustained contractions (endurance): These build the baseline tone and stamina of the pelvic floor:
    • Tighten the pelvic floor muscles as if stopping the flow of urine
    • Hold for 8–10 seconds, breathing normally throughout
    • Fully relax for an equal amount of time
    • Repeat 8–12 times per set
    • Aim for 3 sets per day

  • Quick, fast contractions (speed): These train the pelvic floor to respond rapidly to sudden rises in pressure.
    • Tighten the pelvic floor quickly and firmly, then immediately release
    • Repeat 10–15 times in succession
    • Perform 1–2 sets per day
Vaginal pessary

A vaginal pessary is a removable silicone device placed inside of the vagina by a doctor. It supports and corrects urethral hypermobility. Compared to pessary use for prolapse, pessaries used for stress incontinence have much lower success rates. Other risks of pessaries include discomfort, difficulty with insertion or removal and ulceration of the vagina. In very rare cases a fistula can develop.

Vaginal oestrogen

Vaginal oestrogen therapy is a safe, topical cream which strengthens vaginal tissues. It is a low risk intervention which doesn't cure stress incontinence but improves the health of vaginal tissues and the urinary system as part of management. Occasionally some women can develop a local reaction vaginal oestrogen which usually resolves after cessation of use. There is well established long term data that the use of vaginal oestrogen is safe in women with a previous history of breast cancer.

Lifestyle changes

Avoiding heavy lifting: as over long periods of time recurrent heavy lifting places excessive pressure on the pelvic floor muscles leading to weakness and urethral hypermobility.

Altering bladder habits by undertaking a timed voiding regime and managing fluid intake. A bladder which is less full is less likely to leak.

Managing medical issues

Genito-Urinary Syndrome of Menopause (GSM) which results in vaginal dryness and can exacerbate symptoms of stress incontinence. Correction of this is pertinent for other aspects of women's health particularly sexual function.


Diabetes can weaken vaginal tissues


Obesity places increased pressure on the ligaments and muscles of the pelvic floor and is a key factor that needs to be managed in order to manage stress incontinence.


Constipation in women needs to be treated in order to avoid straining.


General medication review

Surgical management

Surgical treatments are individually detailed below with their specific benefits and risks. .

Dr Usama Shahid will discuss all available options for your stress incontinence as an individualised experience. The decision to proceed with any management is always your choice. All options have been detailed by the Australian Commission on Safety and Quality in Health care document, found here.

Laparoscopic Burch
Colposuspension
What is it?

A laparoscopic Burch colposuspension is a minimally invasive surgical treatment for the correction of stress urinary incontinence. There is no mesh used in this procedure.


Under a general anaesthetic, surgical instruments are inserted through small incisions in the abdomen. Following this, the space above the bladder known as the retro-pubic space (or Cave of Retzius) is dissected. The vaginal tissue around the urethra is then elevated, and suspended with permanent sutures to the ileopectineal ligament above the pubic bone. This bladder neck suspension lifts the vagina thus correcting urethral hypermobility by forming a 'hammock' around the urethra to support it. Consequentially, this prevents leakage of urine with increased abdominal pressure from running, coughing, sneezing and jumping.

What are the risks?

While a laparoscopic Burch colposuspension is a safe procedure, it is not without risk:

The risks include:


  • Recurrence of stress urinary incontinence (10-15%). This may occur over years following the surgery and further surgery may be required to treat incontinence episodes.

  • Bladder symptoms (5%) including urgency and frequency. These symptoms are usually temporary but may persist. Urinary retention or difficulty emptying the bladder (1%) can also occur which may require temporary catherisation. Rarely (<1%) do we need to return to theatre in order to remove the sutures.

  • Bowel symptoms (<1%) including constipation or obstructed defecation.

  • Painful sexual intercourse or dyspareunia (<1%). Overall, sexual function tends to improve if the patient had a cystocele but initially pain may be present.

  • Bleeding: including a risk of haematoma and the need to return to theatre. Rarely, is this the case (<1%) and rarely is a blood transfusion required (<1%). This risk is increased if you are on blood thinners.

  • Injury to surrounding structures (<1%) including the bladder, ureter, bowel, vessels and nerves. This may require further surgery (at the time or later). In rare cases (<1%), a fistula may develop which is an abnormal connection between the bowel or bladder and vagina.

  • Infections may occur involving the urinary tract (5%), port sites or the pelvis. The pubic bone can get infected as well, known as osteomyelitis which may require debridement and long term antibiotics.

  • Post-operative complications include a venous thromboembolism or pulmonary embolism.

  • Exceedingly rare complications include cardiorespiratory arrest, death and the need to convert to an open surgery.
What is recovery like?

Most patients stay in hospital for 1-2 days.

A catheter is inserted after the operation to allow your bladder to rest and this is removed the following morning for a trial of void, to ensure you are urinating well.


In the days following surgery, temporary changes in your bowel and bladder habit are normal. This includes urinary urgency and constipation. In addition, one may experience light vaginal bleeding and discharge. In the vast majority of cases, these symptoms self resolve after 1-2 weeks.

During your stay in hospital and when you return home, you will be provided with adequate pain relief in the form of medications to support your recovery. One of the benefits of a laparoscopic approach is a much quicker recovery compared to open surgery.


You will be provided with a designated phone number to directly contact Dr Shahid following your surgery, should you have any acute concerns. In the case of an emergency, always dial 000.


You can expect some fatigue for the first few days following surgery. During this time, light activities like walking and ensuring you are adequately hydrated are encouraged. This reduces your risk of venous thromboembolism.


You will be contacted by our team and have your post-operative appointment booked in 6 weeks time. We will ensure that you are closely followed up.


What to avoid:

  • Avoid heavy lifting (nothing above 5kg for the first 6 weeks). This is to avoid excessive strain on your healing tissues.

  • Avoid sexual intercourse or anything in the vagina for 6 weeks after the operation.

  • Avoid high impact exercise for 6 weeks

  • Avoid excessive straining when opening your bowels. Ensure you are adequately hydrated and if needed take some over the counter fibre, prune juice and simple laxatives.
Retropubic mid
urethral sling
What is it?

A retropubic mid urethral sling procedure is a minimally invasive surgery used to treat stress urinary incontinence. A narrow permanent strip of synthetic mesh is vaginally placed under the urethra and behind (thus the term 'retro') the pubic bone. This synthetic material forms a sling around the urethra, stabilising it during laughing, coughing, sneezing and running. The procedure has established decades of high success rates, low complications and high patient satisfaction.


Under a general anaesthetic, the bladder is emptied and 2 small incisions are made above the pubic bone. After administering some local anaesthetic to the vagina, an incision is made over the urethra through which the permanent synthetic mesh tape is passed in front of the urethra and exiting behind the pubic bone. A camera is then placed in the bladder to ensure that it was not inadvertently damaged during the procedure. The vaginal incision and exit points behind the pubic bone are then closed with absorbable sutures. If needed vaginal prolapse repairs can be done at the same time as well.

What are the risks?

While retropubic mid urethral sling is a safe procedure, it is not without risk, as is the case in surgeries where no mesh is used.

The risks include:


  • Recurrence of stress urinary incontinence (5-10%). The developing of incontinence again may take years to occur and require other treatments

  • Bladder symptoms (5%) including urgency and frequency. These are usually temporary but may persist. Urinary retention or voiding dysfunction (5%) can also occur which may require temporary catherisation. Rarely (<1%), the vaginal tape may need to be loosened back in theatre. As an exceedingly rare event, sometimes there is no resolve and a partial excision or complete removal of the tape may be required.

  • Bowel symptoms (1%) including constipation or obstructed defecation.

  • Painful sexual intercourse or dyspareunia (2%).

  • Bleeding: including a risk of haematoma and the need to return to theatre. Rarely, is this the case (<1%) and rarely is a blood transfusion required (<1%). This risk is increased if you are on blood thinners.

  • Injury to surrounding structures (<1%) including the bladder, urethra, ureter, bowel, vessels and nerves (may cause reduced sensation). This may require further surgery (at the time or later). In rare cases (<1%), a fistula may develop which is an abnormal connection between the bowel or bladder and vagina.

  • Infections may occur involving the urinary tract (5%), exit sites, vagina or the pelvis.

  • Mesh related complications include: mesh exposure into the vagina (2%). This may cause pain, discharge or sexual dysfunction and require topical oestrogen treatment or further surgery to excise the mesh. The mesh can also expose into the bowel or bladder (<1%) which may require further surgery. Chronic pain may result from mesh procedures. While this is rare (<1%), it may result in partial or complete mesh removal and in a small fraction of these cases the pain does not improve. These complications may present after months to years following surgery.

  • Post-operative complications include a venous thromboembolism or pulmonary embolism.

  • Exceedingly rare complications include cardiorespiratory arrest and death.
What is recovery like?

Most patients stay in hospital for 1 night.


A catheter is inserted after the operation to allow your bladder to rest and this is removed the following morning for a trial of void, to ensure you are urinating well.


If vaginal repairs were performed during the surgery, a vaginal pack is inserted at the end of the procedure which is also removed the following morning.

In the days following surgery, temporary changes in your bowel and bladder habit are normal. This includes urinary urgency, frequency and constipation. In addition, one may experience light vaginal bleeding and discharge. In the vast majority of cases, these symptoms self resolve after 1-2 weeks.

During your stay in hospital and when you return home, you will be provided with adequate pain relief in the form of medications to support your recovery. One of the benefits of a laparoscopic approach is a much quicker recovery compared to open surgery.


You will be provided with a designated phone number to directly contact Dr Shahid following your surgery, should you have any acute concerns. In the case of an emergency, always dial 000.


You can expect some fatigue for the first few days following surgery. During this time, light activities like walking and ensuring you are adequately hydrated are encouraged. This reduces your risk of venous thromboembolism.


You will be contacted by our team and have your post-operative appointment booked in 6 weeks time. We will ensure that you are closely followed up.


What to avoid:

  • Avoid heavy lifting (nothing above 5kg for the first 6 weeks). This is to avoid excessive strain on your healing tissues.

  • Avoid sexual intercourse or anything in the vagina for 6 weeks after the operation.

  • Avoid high impact exercise for 6 weeks

  • Avoid excessive straining when opening your bowels. Ensure you are adequately hydrated and if needed take some over the counter fibre, prune juice and simple laxatives.
Pubovaginal sling
What is it?

A pubovaginal sling is a surgical procedure to treat stress urinary incontinence by supporting the urethra with either:

  • Your own body tissue - rectus sheath (from your abdomen), fascia lata (from the side of your thigh) or

  • Cadaveric tissue donated from a patients rectus sheath. This is a collagen matrix only and does not initiate an immune response like foreign body tissue would.


There is no mesh used in this sling surgery.


Under a general anaesthetic a 'mini laparotomy', similar to a small caeserean section (or bikini line) incision is made and a thin strip (10x2cm) of your rectus sheath is harvested. After dissected behind the pubic bone, a vaginal incision is made and the harvested rectus sheath is used as a sling to support the urethra. The sling is then tied abdominally and the rectus sheath defect closed with absorbable sutures.

Given that a larger incision is required for this procedure through a laparotomy, patients have a longer hospital stay and longer recovery. For this reason, the pubovaginal sling surgery is usually reserved as a secondary treatment, should initial measures fail.

What are the risks?

While a pubovaginal sling is a safe procedure, it is not without risk:


The risks include:

  • Recurrence of stress urinary incontinence (10%). This may occur over years following the surgery. Should the pubovaginal sling fail, management of stress incontinence can be difficult.

  • Bladder symptoms (5%) including urgency and frequency (bladder control problems). These symptoms are usually temporary but may persist. Urinary retention or voiding dysfunction (10%) can also occur which may require temporary catherisation. Compared to other procedures for stress urinary incontinence, pubovaginal slings have higher rates of urinary retention. Rarely (<1%) do we need to return to theatre in order to dissect and loosen the urethral support.

  • Bowel symptoms (2%) including constipation or obstructed defecation.

  • Painful sexual intercourse or dyspareunia (1%).

  • Bleeding: including a risk of haematoma and the need to return to theatre. Rarely, is this the case (<1%) and rarely is a blood transfusion required (<1%). This risk is increased if you are on blood thinners.

  • Injury to surrounding structures (2%) including the bladder, ureter, bowel, vessels and nerves. This may require further surgery (at the time or later). In rare cases (<1%), a fistula may develop which is an abnormal connection between the bowel or bladder and vagina.

  • Infections may occur involving the urinary tract (5%), incision site, vagina or the pelvis.

  • Post-operative complications include a venous thromboembolism or pulmonary embolism. This risk is increased as a pubovaginal sling is an open surgery.

  • Exceedingly rare complications include cardiorespiratory arrest and death.
What is recovery like?

Most patients stay in hospital for 2-3 days.

A catheter is inserted after the operation to allow your bladder to rest and this is removed the following morning for a trial of void, to ensure you are urinating well.


In the days following surgery, temporary changes in your bowel and bladder habit are normal. This includes urinary urgency, frequency and constipation. In addition, one may experience light vaginal bleeding and discharge. In the vast majority of cases, these symptoms self resolve after 1-2 weeks.


During your stay in hospital and when you return home, you will be provided with adequate pain relief in the form of medications to support your recovery. Given that this is an open surgery, there is increased pain following the operation (compared to a laparoscopic procedure) and longer recovery period.


You will be provided with a designated phone number to directly contact Dr Shahid following your surgery, should you have any acute concerns. In the case of an emergency, always dial 000.


You can expect some fatigue for the first few days following surgery. During this time, light activities like walking and ensuring you are adequately hydrated are encouraged. This reduces your risk of venous thromboembolism.


You will be contacted by our team and have your post-operative appointment booked in 6 weeks time. We will ensure that you are closely followed up.


What to avoid:

  • Avoid heavy lifting (nothing above 5kg for the first 6 weeks). This is to avoid excessive strain on your healing tissues.

  • Avoid sexual intercourse or anything in the vagina for 6 weeks after the operation.

  • Avoid high impact exercise for 6 weeks

  • Avoid excessive straining when opening your bowels. Ensure you are adequately hydrated and if needed take some over the counter fibre, prune juice and simple laxatives.
Urethral Bulking Agents
What is it?

Urethral bulking agents are a temporary measure to treat stress incontinence. The procedure uses a special cystoscope to inject a filler known as polyacrylamide hydrogel into the sub-mucosal layer of the urethra. This doesn't correct urethral hypermobility but rather increases urethral resistance and helps improve the sphincters closure mechanism, thereby decreasing urinary leakage.


Compared to other interventions for stress incontinence, urethral bulking agents have a lower success rate. But given there is no mesh and no vaginal or abdominal incisions it is a very low risk procedure with almost no recovery period. In addition, the body naturally absorbs the bulking agent over time, thus it only works for 9-12 months and further bulking agent injections are required thereafter.


For these reasons, the procedure is usually reserved for women who may not be suitable for a major surgery (due to frailty or significant medical issues) and prefer a less invasive option understanding the lower success rates.

What are the risks?

While urethral bulking agent is a safe procedure, it is not without risk:

The risks include:


  • Recurrence of stress urinary incontinence (40%). This may occur weeks to months following the surgery. The body absorbs the bulking agent usually over a period of 9 months and further surgical treatment options are usually required.

  • Bladder symptoms (5%) including urgency and frequency and loss of bladder control. These symptoms are usually temporary but may persist. Urinary retention or voiding dysfunction (<1%) is rare but may require catherisation.

  • Migration of the bulking agent, formation of nodules, scarring urethra (<1%).

  • Painful sexual intercourse or dyspareunia (1%).

  • Bleeding: including a risk of haematoma and the need to return to theatre. Rarely, is this the case (<1%) and rarely is a blood transfusion required (<1%). This risk is increased if you are on blood thinners.

  • Injury to surrounding structures (<1%) including the bladder, urethra, ureter, bowel, vessels and nerves. This may require further surgery (at the time or later). In rare cases (<1%), a fistula may develop which is an abnormal connection between the bowel or bladder and vagina.

  • Infections may occur involving the urinary tract (5%).

  • Post-operative complications include a venous thromboembolism or pulmonary embolism.

  • Exceedingly rare complications include cardiorespiratory arrest and death.
What is recovery like?

Urethral bulking agents is a day procedure, meaning there is no overnight stay in hospital.


Following the procedure there is no catheter and in recovery the nurses perform a trial of void to make sure you are urinating well.

In the days following surgery, changes in your bladder habit are normal. This includes urinary urgency and frequency. In addition, one may experience light vaginal bleeding and discharge. In the vast majority of cases, these symptoms self resolve after 1-2 days.


During your stay in hospital and when you return home, you will be provided with adequate pain relief in the form of medications to support your recovery. There is usually little to no pain following urethral bulking agents.


You will be provided with a designated phone number to directly contact Dr Shahid following your surgery, should you have any acute concerns. In the case of an emergency, always dial 000.


You can expect some fatigue for the first few days following surgery. During this time, light activities like walking and ensuring you are adequately hydrated are encouraged. This reduces your risk of venous thromboembolism.


You will be contacted by our team and have your post-operative appointment booked in 6-8 weeks time. We will ensure that you are closely followed up.


What to avoid:

There are no specific restrictions following urethral bulking agents, but it is wise to avoid heavy lifting, high impact exercise and sexual intercourse in the post operative periods (ie: the first 3 days).

  • Avoid excessive straining when opening your bowels. Ensure you are adequately hydrated and if needed take some over the counter fibre, prune juice and simple laxatives.
Why choose Dr Usama Shahid as your stress urinary incontinence subspecialist?

Leaking with laughing, coughing, sneezing or exercise is common, but it is not normal and you don't have to put up with it. With highly subspecialised Urogynaecology training in stress urinary incontinence, Dr Shahid brings to the Illawarra the regions first full time Urogynaecology service.

Through experience in high volume centres, publications of world renowned research and a broad clinical and surgical expertise, Dr Shahid brings a comprehensive and holistic approach in the community he calls home, centring his up to date practice around their care. With an ever growing population in the Illawarra and an increased awareness of stress urinary incontinence, Dr Shahid hopes to restore a sense of normality and confidence to the women he treats.

You don't have to live with leakage.

Why choose Dr Usama Shahid as your stress urinary incontinence subspecialist?

Frequently Asked Questions

Do I need surgery for prolapse or urinary incontinence?

Not necessarily. Management options involve doing watching and waiting (and observing progress), conservative (or non surgical options) and then surgical options. Dr Shahid will discuss all available options for your prolapse as an individualised experience. The decision to proceed with any management is always your choice.

When can I return to work following surgery?
  • This depends on the nature of your employment, your background health and the type of surgery you have had.
  • For most patients if you work from a desk, the discomfort after surgery usually subsides fully at around the 2 week mark but most patients return back to work 4 weeks after major surgery.
  • If your job involves lifting >5kg (and no other duties can be allocated to you), then we recommend you take a full 6 weeks off work following surgery, to allow your body to fully heal.
When can I drive after surgery?
  • This depends on the nature of your employment, your background health and the type of surgery you have had.
  • For most patients if you work from a desk, the discomfort after surgery usually subsides fully at around the 2 week mark but most patients return back to work 4 weeks after major surgery.
  • If your job involves lifting >5kg (and no other duties can be allocated to you), then we recommend you take a full 6 weeks off work following surgery, to allow your body to fully heal.
What should I avoid doing after surgery?
  • Avoid heavy lifting (nothing above 5kg for the first 6 weeks). This is to avoid excessive strain on your healing tissues.
  • Avoid sexual intercourse or anything in the vagina for 6 weeks after the operation.
  • Avoid high impact exercise for 6 weeks
  • Avoid excessive straining when opening your bowels. Ensure you are adequately hydrated and if needed take some over the counter fibre, prune juice and simple laxatives.
What are the consultation or operating fees?
  • We focus on providing clear, transparent pricing. Because every patient’s situation is slightly different, we provide a personalised, itemised quote after your consultation – so you know exactly what to expect before making any decisions.
  • Urogynaecology procedures do have Medicare rebates but the exact out-of-pocket cost varies depending on the type of procedure, your private health insurance and individual situation.
  • Please contact our rooms for further queries.
Do I need a referral to see a urogynaecologist?

Yes, referrals are required in order for you to obtain Medicare rebates. Please see your GP and mention you want a referral to see Dr Usama Shahid or otherwise contact our rooms and we will guide you to known GP’s for referrals. 

When should I see a urogynaecologist?

Anytime you are bothered by your symptoms and they are affecting your quality of life. All options for management will be openly discussed with you. There are treatments available. 

What happens during a urogynaecology consultation?

Pelvic floor health is personal, and Dr Shahid understands that. He is committed to making every patient feel at ease. Your first consultation is an opportunity to discuss your symptoms in a confidential, supportive environment. Dr Shahid will take a history, perform an examination to assess your pelvic floor and if needed do further tests like urodynamics and ultrasound before having a robust discussion about options available to you. Thus allowing you to make an informed decision about your care. 

Get in touch.
We’re here to help.

Whether you have a question, want to make an appointment, or your GP would like to refer a patient, we’d love to hear from you.